{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:40:29Z","timestamp":1661301629004},"reference-count":60,"publisher":"Index Copernicus","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol Przegl Chir"],"published-print":{"date-parts":[[2017,10,31]]},"abstract":"<jats:p>The \u201cPolish Research on Gastric Cancer\u201d project has been continued since 1986. The main aim of this project, which is a multicenter and interdisciplinary research, is enhancing the treatment results of gastric cancer patients by developing and promoting the use of optimal methods for diagnosis and treatment, both surgical as well as combined. One of the more important achievements of the project is the development and publication of a document named \u201cPolish Consensus on Treatment of Patients with Gastric Cancer\u201d, whose first version was published in 1998. Following versions were updated adequately to changing trends in the proceedings in patients with gastric cancer. A scientific symposium on \u201cPolish Consensus on Treatment of Gastric Cancer \u2013 update 2016\u201d was held in 3-4 June 2016 in Cracow. During the symposium a panel session was held during which all authors publicly presented the Consensus assumptions to be discussed further. Moreover, the already mentioned session was preceded by a correspondence as well as a working meeting in order to consolidate the position. It has to be underlined that the directions and guidelines included in the Consensus are not the arbitrarily assumed rules of conduct in a legal aspect and as such every doctor\/team of doctors is entitled to make different decisions as long as they are beneficial to a patient with gastric cancer. The Consensus discusses as follows: a) recommended qualifications (stage of advancement, pathological, lymph node topography and the extent of lymphadenectomy, division of cancer of the gastroesophageal junction), b) rules for diagnostics including recommendations regarding endoscopic examination and clinical evaluation of the advancement stage, c) recommendations regarding surgical treatment (extent of resection, extent of lymphadenectomy, tactics of proceedings in cancer of the gastroesophageal junction), d) recommendations regarding combined treatment with chemotherapy or radiotherapy, e) place of endoscopic and less invasive surgery in the treatment of gastric cancer. This publication is a summary of the arrangements made in the panel session during the abovementioned scientific symposium in Cracow in 2016.<\/jats:p>","DOI":"10.5604\/01.3001.0010.5413","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T09:27:34Z","timestamp":1526981254000},"page":"59-73","source":"Crossref","is-referenced-by-count":1,"title":["Polish Consensus on Treatment of Gastric Cancer; update 2017"],"prefix":"10.5604","volume":"89","author":[{"given":"Jan","family":"Kulig","sequence":"first","affiliation":[{"name":"1st Department of General Surgery and Clinic of General Surgery, Oncological Surgery and Gastroenterological Surgery, Jagiellonian University Medical College in Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Wallner","sequence":"additional","affiliation":[{"name":"2nd Department and Clinic of General, Gastroenterological and Gastrointestinal Cancer Surgery, Medical University in Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Drews","sequence":"additional","affiliation":[{"name":"Department and Clinic of General Surgery, Gastroenterological Surgery and Plastic Surgery, Medical University in Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Fr\u0105czek","sequence":"additional","affiliation":[{"name":"Department and Clinic of General, Transplantation and Liver Surgery, Warsaw Medical University, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkadiusz","family":"Jeziorski","sequence":"additional","affiliation":[{"name":"Clinic of Oncological Surgery, Medical University in Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Kielan","sequence":"additional","affiliation":[{"name":"2nd Department and Clinic of General Surgery and Oncological Surgery, Medical University in Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ko\u0142odziejczyk","sequence":"additional","affiliation":[{"name":"1st Department of General Surgery and Clinic of General Surgery, Oncological Surgery and Gastroenterological Surgery, Jagiellonian University Medical College in Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nasierowska-Guttmejer","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Unit, Central Clinical Hospital of the Ministry of the Interior in Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Starzy\u0144ska","sequence":"additional","affiliation":[{"name":"Department and Clinic of Gastroenterology, Pomeranian Medical University in Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Zinkiewicz","sequence":"additional","affiliation":[{"name":"2nd Department and Clinic of General, Gastroenterological and Gastrointestinal Cancer Surgery, Medical University in Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Wojtukiewicz","sequence":"additional","affiliation":[{"name":"Clinic of Oncology, Medical University in Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Tomasz","family":"Skoczylas","sequence":"additional","affiliation":[{"name":"2nd Department and Clinic of General, Gastroenterological and Gastrointestinal Cancer Surgery, Medical University in Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Richter","sequence":"additional","affiliation":[{"name":"1st Department of General Surgery and Clinic of General Surgery, Oncological Surgery and Gastroenterological Surgery, Jagiellonian University Medical College in Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Krawczyk","sequence":"additional","affiliation":[{"name":"Department and Clinic of General, Transplantation and Liver Surgery, Warsaw Medical University, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"154563r1","unstructured":"Edge S.B., Byrd D.R., Compton C.C. et.al.: AJCC Cancer Staging Manual. 7th ed. New York \u2013 Dordrecht \u2013 Heidelberg \u2013 London: Springer, 2010."},{"key":"154563r2","doi-asserted-by":"crossref","unstructured":"Greene F.L. Page D.I. et.al.: AJCC cancer staging manual. 6th ed. New York: Springer Verlag, 2002.","DOI":"10.1007\/978-1-4757-3656-4"},{"key":"154563r3","unstructured":"McGhan L.J., Pockaj B.A., Gray R.J. et. al.: Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma. J. Gastrointestsurg. 2012; 16: 53\u201361."},{"key":"154563r4","unstructured":"Nasierowska-Guttmejer A., Majewski P., Malinowska M.: Czynniki prognostyczne i\u00a0predykcyjne w\u00a0raku \u017co\u0142\u0105dka. Pol. J. Pathol. 2013; supl 1."},{"key":"154563r5","unstructured":"Lauwers G.Y., Carneiro F., Graham D.Y. et al.: Gastric carcinoma. In: Bosman F.T., Carneiro F., Hruban R.H., Theise N.D. (eds): WHO Classification of tumours of the digestive system, 4th edn. IARC. Lyon, 2010: 48\u201358."},{"key":"154563r6","doi-asserted-by":"crossref","unstructured":"Dinis-Ribeiro M., Areia M., de Vries A.C. et al.: Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Society of Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows. Arch. 2012; 460: 19\u201346.","DOI":"10.1007\/s00428-011-1177-8"},{"key":"154563r7","doi-asserted-by":"crossref","unstructured":"Okines A., Verheij M., Allum W. et al.: Gastric cancer. ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. On behalf of the ESMO Guidelines Working Group. Annals of Oncology. 2010; 21 (Suppl. 5): 50\u201354.","DOI":"10.1093\/annonc\/mdq164"},{"key":"154563r8","doi-asserted-by":"crossref","unstructured":"Fujishiro M.: Perspective on the practical indications of endoscopic submucosal dissection of gastrointestinal neoplasms. World J. Gastroenterol. 2008; 14: 4289\u20134295","DOI":"10.3748\/wjg.14.4289"},{"key":"154563r9","doi-asserted-by":"crossref","unstructured":"Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, Park SR, Fujii M, Kang YK, Chen LT. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013 Nov;14: 535-547","DOI":"10.1016\/S1470-2045(13)70436-4"},{"key":"154563r10","doi-asserted-by":"crossref","unstructured":"Akahoshi K., Akahane H.: A\u00a0new breakthrough: ESD using a\u00a0newly developed grasping type scissor forceps for early gastrointestinal tract neoplasms. World J. Gastrointest. Endosc. 2010; 16: 90\u201396.","DOI":"10.4253\/wjge.v2.i3.90"},{"key":"154563r11","doi-asserted-by":"crossref","unstructured":"Probst A., Pommer B., Golger D. et al.: Endoscopic submucosal dissection in gastric neoplasia \u2013 experience from a\u00a0European center Endoscopy. 2010; 42: 1037\u20131044.","DOI":"10.1055\/s-0030-1255668"},{"key":"154563r12","doi-asserted-by":"crossref","unstructured":"Sano T., Aiko T.: New Japanese classification and treatment guidelines for gastric cancer: revision concepts and major revised points. The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2011. Gastric Cancer Treatment Guidelines 2010, version 3. Gastric. Cancer. 2011; 14: 97\u2013100.","DOI":"10.1007\/s10120-011-0040-6"},{"key":"154563r13","doi-asserted-by":"crossref","unstructured":"Washington K.: 7th Edition of the AJCC Cancer Staging Manual: Stomach. Ann. Surg. Oncol. 2010; 17: 3077\u20133079.","DOI":"10.1245\/s10434-010-1362-z"},{"key":"154563r14","doi-asserted-by":"crossref","unstructured":"Lauren P.: The two histological main types of gastrin carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a\u00a0histo-clinical classification. Microbiol. Scand. 1965; 64: 31\u201349.","DOI":"10.1111\/apm.1965.64.1.31"},{"key":"154563r15","unstructured":"Olszewski W.P., Olszewski W.T.: Rola patomorfologa w\u00a0doborze terapii ukierunkowanej na receptor czynnika wzrostu nask\u00f3rka (EGFR) u\u00a0chorych na nowotwory. Onkol. Prak. Klin. 2010; 6: 228\u2013235."},{"key":"154563r16","doi-asserted-by":"crossref","unstructured":"Hofmann M., Stoss O., Shi D. et al.: Assessment of a\u00a0HER2 scoring system for gastric cancer: results from a\u00a0validation study. Histopathology. 2008; 52: 797\u2013c805.","DOI":"10.1111\/j.1365-2559.2008.03028.x"},{"key":"154563r17","doi-asserted-by":"crossref","unstructured":"Ruschoff J., Dietel M., Baretton G. et al.: HER2 diagnostics in gastric cancer \u2013 guideline validation and development of standardized immunohistochemical testing. Virchows. Arch. 2010; 457: 2999\u20132307.","DOI":"10.1007\/s00428-010-0952-2"},{"key":"154563r18","doi-asserted-by":"crossref","unstructured":"Ruschoff J., Wedad H., Michael B. et al.: HER2 testing in gastric cancer: a\u00a0practical approach. Modern Pathology. 2012, 1\u201314.","DOI":"10.1038\/modpathol.2011.198"},{"key":"154563r19","unstructured":"Gospodarowicz M., Wittekind Ch., Sobin L.H.: International Union Against Cancer TNM 7th edition. Gastric cancer. (2010). www.uicc.org."},{"key":"154563r20","doi-asserted-by":"crossref","unstructured":"Dikken J.L., van de Velde C.J.: The New AJCC\/IUAC staging system for adenocarcionoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann. Surg. Oncol. 2012; 19: 2443\u20132451.","DOI":"10.1245\/s10434-012-2403-6"},{"key":"154563r21","doi-asserted-by":"crossref","unstructured":"Siewert J.R., Stein H.J.: Classification of adenocarcinoma of the oesophagogastric junction. Br. J. Surg. 1998; 85: 1457\u20131459.","DOI":"10.1046\/j.1365-2168.1998.00940.x"},{"key":"154563r22","doi-asserted-by":"crossref","unstructured":"Yao K.: The endoscopic diagnosis of early gastric cancer. Ann. Gastroenterol. 2013; 26: 11\u201322. 23. Muto M., Yao K., Kaise M. et al: Magnifying endoscopy simple diagnostic algorithm for early gastric cancer ( MESDA- G). Digestive Endoscopy. 2016; 28: 379\u2013393 .","DOI":"10.1111\/den.12638"},{"key":"154563r23","doi-asserted-by":"crossref","unstructured":"Uto M, Yao K, Kaise M et al Magnifying endoscopy simple diagnostic algorithm for early gastric cancer ( MESDA- G). Digestive Endoscopy 2016;28: 379-393","DOI":"10.1111\/den.12638"},{"key":"154563r24","doi-asserted-by":"crossref","unstructured":"Uto M, Yao K, Kaise M et al Magnifying endoscopy simple diagnostic algorithm for early gastric cancer ( MESDA- G). Digestive Endoscopy 2016;28: 379-393","DOI":"10.1111\/den.12638"},{"key":"154563r25","doi-asserted-by":"crossref","unstructured":"Nagahama T., Yao K., Imamurs K. et al.: Diagnostic performance of conventional endoscopy in the identification of submucosal invasion by\u00a0early gastric cancer: the \u201cnon-extension sign\u201d as a\u00a0simple diagnostic marker. Gastric. Cancer. 2016 in press.","DOI":"10.1007\/s10120-016-0612-6"},{"key":"154563r26","unstructured":"Ang T.L., Khor C.J., Gotoda T.: Diagnosis and endoscopic resection of early gastric cancer. Singapore Med. J. 2010; 51: 93\u2013100"},{"key":"154563r27","doi-asserted-by":"crossref","unstructured":"Dumonceau J.-M., Polkowski M., Larghi A. et al.: Indications, results, and clinical impact of endosopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2011; 43: 897\u2013909 .","DOI":"10.1055\/s-0030-1256754"},{"key":"154563r28","doi-asserted-by":"crossref","unstructured":"Lutz M.P., Zalcberg J.R., Ducreux M. et.al.: Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and esophageal cancer. European Journal of Cancer. 2012; 48, 2941\u20132953.","DOI":"10.1016\/j.ejca.2012.07.029"},{"key":"154563r29","doi-asserted-by":"crossref","unstructured":"Cardoso R., Coburn N., Seevaratnam R. et al.: A\u00a0systemic review and metaanalysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer. 2012; 15 Supp1: 19\u201326.","DOI":"10.1007\/s10120-011-0115-4"},{"key":"154563r30","doi-asserted-by":"crossref","unstructured":"Lee H.H., Lee S.-Y., Yoon H.Y. et.al.: Change of mucosal color in early gastric cancer. Journal of Digestive Diseases .2012, 13: 510\u2013516.","DOI":"10.1111\/j.1751-2980.2012.00620.x"},{"key":"154563r31","doi-asserted-by":"crossref","unstructured":"Siewert J.R., B\u00f6ttcher K., Roder J.D. et.al.: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br. J. Surg. 1993; Aug.; 80 (8): 1015\u20131018.","DOI":"10.1002\/bjs.1800800829"},{"key":"154563r32","doi-asserted-by":"crossref","unstructured":"Roukos D.H., Paraschou P., Lorenz M.: Distal gastric cancer and extensive surgery: a\u00a0new evaluation method based on the study of the status of residual lymph nodes after limited surgery. An. Surg. Oncol. 2000 Dec.; 7 (10): 719\u2013726.","DOI":"10.1007\/s10434-000-0719-0"},{"key":"154563r33","doi-asserted-by":"crossref","unstructured":"Piso P., Werner U., Lang H. et.al.: Proximal versus distal gastric carcinoma-what are the differences? Ann. Surg. Oncol. 2000; 7 (7): 520\u2013525.","DOI":"10.1007\/s10434-000-0520-0"},{"key":"154563r34","doi-asserted-by":"crossref","unstructured":"Bozzetti F., Marubini E., Bonfanti G. et.al.: Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a\u00a0multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann. Surg. 1999 Aug.; 230 (2): 170\u2013178","DOI":"10.1097\/00000658-199908000-00006"},{"key":"154563r35","unstructured":"Sano T., Kodera Y.: The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2011. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric cancer 2011; 14: 101\u2013112."},{"key":"154563r36","unstructured":"Sano T., Kodera Y.: The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2011. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric cancer 2011; 14: 113\u2013123."},{"key":"154563r37","unstructured":"Sasson A.R. et al.: NCCN Clinical Practice Guidelines in Oncology. (National Comprehensive Cancer Network, version 2. 2012). Gastric Cancer NCCN Guidelines \u2013 including cancer in the proximal 5 cm of the stomach. www. nccn.org."},{"key":"154563r38","doi-asserted-by":"crossref","unstructured":"Sasako M., Sano T., Yamamoto S. et al.: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N. Engl. J. Med. 2008, 359 (5): 453\u2013456.","DOI":"10.1056\/NEJMoa0707035"},{"key":"154563r39","doi-asserted-by":"crossref","unstructured":"Wang Z., Chen J.-Q. et al.: Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer. World J. Gastroenterol. 2010; 16: 1138\u20131149","DOI":"10.3748\/wjg.v16.i9.1138"},{"key":"154563r40","doi-asserted-by":"crossref","unstructured":"Kulig J., Popiela T., Kolodziejczyk P., Sierzega M. on behalf of the Polish Gastric Cancer Study Group: Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a\u00a0multicenter, randomized, clinical trial. Am. J. Surg. 2007, 193 (1): 10\u201315.","DOI":"10.1016\/j.amjsurg.2006.04.018"},{"key":"154563r41","doi-asserted-by":"crossref","unstructured":"Sano T., Yamamoto S., Sasako M., Japan Clinical Oncology Group Study LCOG 0110-MF: Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. Jpn. J. Clin. Oncol. 2002; 32 (9): 363\u2013364.","DOI":"10.1093\/jjco\/hyf085"},{"key":"154563r42","doi-asserted-by":"crossref","unstructured":"Sasako M., Sano T., Yamamoto S., (JCOG9502) et al.: Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a\u00a0randomised controlled trial. Lancet Oncol. 2006, 7 (8): 644\u2013651.","DOI":"10.1016\/S1470-2045(06)70766-5"},{"key":"154563r43","unstructured":"Hiroshi O., Yutaka T., Kozo N. et al.: A\u00a0Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a\u00a0Cochrane review. Gastrointest. Surg. 2010; 14: 958\u2013964."},{"key":"154563r44","doi-asserted-by":"crossref","unstructured":"Byung Hee Kang, Yi Xuan, Hoon Hur et.al.: Comparison of Surgical Outcomes between Robotic and Laparoscopic Gastrectomy for Gastric Cancer: The Learning Curve of Robotic Surgery. J. Gastric Cancer. 2012; 12 (3): 156\u2013163.","DOI":"10.5230\/jgc.2012.12.3.156"},{"key":"154563r45","doi-asserted-by":"crossref","unstructured":"Yang H.K., Suh Y.S., Lee H.J.: Minimally invasive approaches for gastric cancer-Korean experience. J. Surg. Oncol. 2012 Jul. 17.","DOI":"10.1002\/jso.23179"},{"key":"154563r46","doi-asserted-by":"crossref","unstructured":"Rausei S., Dionigi S., Rovera F.: A\u00a0decade in gastric cancer curative surgery: Evidence of progress (1999-2009). World J. Gastrointest. Surg. 2012; 4.(3): 45\u201354.","DOI":"10.4240\/wjgs.v4.i3.45"},{"key":"154563r47","doi-asserted-by":"crossref","unstructured":"Saka M., Morita S., Fukagawa T., Katai H.: Present and Future Status of Gastric Cancer Surgery. Jpn. J. Clin. Oncol. 2011; 41 (3): 307\u2013313.","DOI":"10.1093\/jjco\/hyq240"},{"key":"154563r48","doi-asserted-by":"crossref","unstructured":"Alonso-L\u00e1rraga J.O., Alvaro-Villegas J.C., Sobrino-Coss\u00edo S., Hern\u00e1ndez-Guerrero A., de-la-Mora-Levy G., Figueroa-Barojas P.: Self-expanding metal stents versus antrectomy for the palliative treatment of obstructive adenocarcinoma of the gastric antrum. Rev. Esp. Enferm. Dig. 2012 Apr.; 104 (4): 185\u2013189.","DOI":"10.4321\/S1130-01082012000400003"},{"key":"154563r49","doi-asserted-by":"crossref","unstructured":"Meyer H., Wilke, H.: Treatment Strategies in Gastric Cancer. Dtsch. Arztebl. Int. 2011; 108 (41): 698\u2013706.","DOI":"10.3238\/arztebl.2011.0698"},{"key":"154563r50","doi-asserted-by":"crossref","unstructured":"Kakeji Y., Morita M., Maehara Y.: Strategies for treating liver metastasis from gastric cancer. Surg. Today. 2010 Apr.;40 (4): 287\u2013294.","DOI":"10.1007\/s00595-009-4152-0"},{"key":"154563r51","doi-asserted-by":"crossref","unstructured":"Cunningham D., Allum W.H., Stenning S.P. et al. and MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Eng. J. Med. 2006 Jul. 6; 355 (1): 11\u201320.","DOI":"10.1056\/NEJMoa055531"},{"key":"154563r52","doi-asserted-by":"crossref","unstructured":"Ychou M., Boige V., Pignon J.P. et. al.: Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J. Clin. Oncol. 2011, 1, 29.","DOI":"10.1200\/JCO.2010.33.0597"},{"key":"154563r53","doi-asserted-by":"crossref","unstructured":"Smalley S.R., Benedetti J.K., Haller D.G. et. al.: SWOG-directed intergroup study 0116: a\u00a0phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J. Clin. Oncol. 2012 Jul. 1; 30 (19): 2327\u20132333.","DOI":"10.1200\/JCO.2011.36.7136"},{"key":"154563r54","doi-asserted-by":"crossref","unstructured":"Cunningham D., Starling N., Rao S. et al.: Capecitabine and oxaliplatin for advanced esophagogastric cancer. N. Engl. J. Med. 2008; 358: 36\u201346.","DOI":"10.1056\/NEJMoa073149"},{"key":"154563r55","doi-asserted-by":"crossref","unstructured":"Kang Y.K., Kang W.K., Shin D.B. et al.: Capecitabine\/cisplatin versus 5-fluorouracil\/ cisplatin as first-line therapy in patients with advanced gastric cancer: a\u00a0randomised phase III noninferiority trial. Ann. Oncol. 2009; 20: 666\u2013673.","DOI":"10.1093\/annonc\/mdn717"},{"key":"154563r56","doi-asserted-by":"crossref","unstructured":"Okines A.F., Norman A.R., McCloud P. et al.: Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann. Oncol. 2009; 20: 1529\u20131534.","DOI":"10.1093\/annonc\/mdp047"},{"key":"154563r57","doi-asserted-by":"crossref","unstructured":"van Cutsem E., Chung H., Shen L.: Efficacy results from the ToGA trial: A\u00a0phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC) In ASCO Annual Meeting, Orlando, FL, USA. J. Clin. Oncol. 2009; LBA 4509.","DOI":"10.1200\/jco.2009.27.18_suppl.lba4509"},{"key":"154563r58","doi-asserted-by":"crossref","unstructured":"Thuss-Patience P.C., Deist T., Hinke A.: Irinotecan versus best supportive care (BSC) as second-line therapy in gastric cancer: a\u00a0randomized phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) In ASCO Annual Meeting,Orlando, FL, USA. J. Clin. Oncol. 2009; Abstr. 4540.","DOI":"10.1016\/S1359-6349(09)71226-1"},{"key":"154563r59","doi-asserted-by":"crossref","unstructured":"Dank M., Zaluski J., Barone C. et al.: Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction. Ann. Oncol. 2008; 19: 1450\u20131457.","DOI":"10.1093\/annonc\/mdn166"},{"key":"154563r60","doi-asserted-by":"crossref","unstructured":"Kulig J., Kolodziejczyk P., Kulig P., Legutko J.: Targeted therapy for gastric cancer - current status. Oncol. Pharm. Practice. 19 (1) 75\u201381.","DOI":"10.1177\/1078155212449030"}],"container-title":["Polish Journal of Surgery"],"original-title":[],"link":[{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0010.5413","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ppch.pl\/gicid\/pdf\/01.3001.0010.5413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:11:17Z","timestamp":1661299877000},"score":1,"resource":{"primary":{"URL":"https:\/\/ppch.pl\/gicid\/01.3001.0010.5413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10,31]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0010.5413","relation":{},"ISSN":["0032-373X","2299-2847"],"issn-type":[{"value":"0032-373X","type":"print"},{"value":"2299-2847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]}}}